GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » 3-Year Revenue Growth Rate

King International Investment (HKSE:00928) 3-Year Revenue Growth Rate : 18.70% (As of Sep. 2024)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment 3-Year Revenue Growth Rate?

King International Investment's Revenue per Share for the six months ended in Sep. 2024 was HK$0.02.

During the past 12 months, King International Investment's average Revenue per Share Growth Rate was -35.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 18.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 21.90% per year. During the past 10 years, the average Revenue per Share Growth Rate was 20.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of King International Investment was 81.70% per year. The lowest was -89.20% per year. And the median was 2.40% per year.


Competitive Comparison of King International Investment's 3-Year Revenue Growth Rate

For the Diagnostics & Research subindustry, King International Investment's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where King International Investment's 3-Year Revenue Growth Rate falls into.


;
;

King International Investment 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


King International Investment  (HKSE:00928) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


King International Investment 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of King International Investment's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment Business Description

Traded in Other Exchanges
N/A
Address
No. 338 King’s Road, Suite 2001, 20th floor, Two Chinachem Exchange Square, North Point, Hong Kong, HKG
King International Investment Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business, Money lending business and sales of liquor business. It generates maximum revenue from the sales of liquor business segment. Geographically, it derives a majority of revenue from PRC. The group is a provider of genetic testing and health data analysis services.
Executives
Wei Yan 2101 Beneficial owner
Wang Mengyao 2101 Beneficial owner
Wong Yat Fung 2101 Beneficial owner
Zhou Chun Yan 2101 Beneficial owner
Pioneer Environmental International Industries Company Limited 2101 Beneficial owner
Liu Na 2201 Interest of corporation controlled by you
Wang Wen 2101 Beneficial owner
Pang Zhen 2101 Beneficial owner

King International Investment Headlines

No Headlines